Metabolic effects of incremental doses of intraperitoneal amino acids on automated peritoneal dialysis

Peritoneal Dialysis International

Volumn 30, Issue 2, 2010, Pages 201-207

  McCormick, Brendan B ^a,b   Mujais, Salim ^c   Poirier, Francine ^b   Page, Nicole ^b   Lavoie, Susan ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Hospital Centre for Kidney Disease   (Canada)

^c ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

Author keywords

Amino acids; Automated peritoneal dialysis; Glucose sparing; Metabolic acidosis; Nutrineal; Ultrafiltration

Indexed keywords

AMINO ACID; BICARBONATE; DIANEAL; LACTIC ACID; NUTRINEAL; PERITONEAL DIALYSIS FLUID; PHYSIONEAL; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOMATED PERITONEAL DIALYSIS; BICARBONATE BLOOD LEVEL; BLOOD PH; CHEMICAL COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIALYSATE; DIET SUPPLEMENTATION; FEMALE; HUMAN; KIDNEY FAILURE; MALE; METABOLIC DISORDER; OPEN STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PILOT STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; ULTRAFILTRATION;

ADULT; AGED; AMINO ACIDS; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; PILOT PROJECTS;

EID: 77957571570     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00040     Document Type: Article

References (18)

1. Khanna R, Twardowski ZJ, Oreopoulos DG. Osmotic agents for peritoneal dialysis. Int J Artif Organs 1986; 9:387-90.
2. Maurer O, Saxenhofer H, Jaeger P, Casez JP, Descoeudres C, Horber FF. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass. Clin Nephrol 1996; 45:303-9.
3. Jones M, Hagen T, Boyle CA, Vonesh E, Hamburger R, Charytan C, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis 1998; 32:761-9.
4. Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 2003; 42: 173-83.
5. Kopple JD, Bernard D, Messana J, Swartz R, Bergstrom J, Lindholm B, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int 1995; 47:1148-57.
6. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 2002; 61:1286-92.
7. Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, van Dijk LJ, van der Wiel AM, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 2005; 16:1486-93.
8. le Poole CY, Welten AG, Weijmer MC, Valentijn RM, van Ittersum FJ, ter Wee, PM. Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious. Perit Dial Int 2005; 25(Suppl 3):S64-8.
9. Waniewski J, Werynski A, Heimburger, Park MS, Lindholm B. Effect of alternative osmotic agents on peritoneal transport. Blood Purif 1993; 11:248-64.
10. Olszowksa A, Waniewski J, Werynski A, Anderstam B, Lindholm B, Wankowicz Z. Peritoneal transport in peritoneal dialysis patients using glucose-based and amino acidbased solutions. Perit Dial Int 2007; 27:544-53.
11. Twardowski Z, Nolph KO, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull 1987; 7:138-48.
12. Vande Walle JG, Raes AM, Dehoorne J, Maneul R. Use of bicarbonate/lactate-buffered dialysate with a nighttime cycler, associated with a daytime dwell with icodextrin, may result in alkalosis in children. Adv Perit Dial 2004; 20: 222-5.
13. Dratwa M, Wilkie M, Ryckelynck JP, ter Wee PM, Rutherford P, Michel C, et al. Clinical experience with two physiologic bicarbonate/lactate peritoneal dialysis solutions in automated peritoneal dialysis. Kidney Int Suppl 2003; 88:S105-13.
14. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol 2003; 148:2119-26.
15. Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). Kidney Int 2003; 64:1480-6.
16. Martikainen T, Teppo AM, Gronhagen-Riska C, Ekstrand A. Benefit of glucose-free dialysis solutions on glucose and lipid metabolism in peritoneal dialysis patients. Blood Purif 2005; 23:303-10.
17. Medcalf JF, Harris KP, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 2001; 59: 1128-33.
18. Holmes C, Mujais S. Glucose sparing in peritoneal dialysis: implications and metrics. Kidney Int Suppl 2006; 103: S104-9.